维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Mustea A"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Vascular endothelial growth factor gene polymorphisms are associated with prognosis in Ovarian cancer显示文摘	Hefler LA Mustea A Konsgen D	2007	Clin Cancer Res2007，13，3：	1
2	Polymorphism of IL-1 receptor antagonist gene:role in cancer显示文摘	Sehouli J Mustea A Konsgen D	2002	Anticancer Res2002，22，6：	1
3	Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer显示文摘	Mustea A Pirvulescu C Konsgen D	2008	Cytokine2008，42，1：	1
4	Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer显示文摘	Hefler LA Mustea A KSnsgen D	2007	Clin Cancer Res2007，13，：	1
5	Interleukin 1 receptor antagonist(IL-1 RA) Polymorphism in women with cervical cancer 显示文摘	Mustea A Sehouli J Konsgen D	2003	Anticancer Res2003，23，2：	1
6	Weekly paclitaxel and carboplatin (PC-W)for patients with primary advanced ovarian cancer:results of a multicenter phase-II study of the NOGGO 显示文摘	Sehouli J Stengel D Mustea A	2008	Cancer Chemother Pharmacol2008，61，：	1
7	Adjuvant s- equential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, muhicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology) 显示文摘	MUSTEA A KOENSGEN D BELAU A	2013	Cancer Chemother Pharmacol2013，72，5：	1
8	Optimization of medium components in vitamin B12 biosynthesis 显示文摘	Roman R V Iluc E Mustea A etal	2001	Roum Biotechnol Lett2001，6，：	1
9	Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer 显示文摘	Sehouli J Mustea A Koensgen D	2003	Cancer Epidemiol Biomarkers Prey2003，12，11：	1
10	Granulosa cell tumor of the Ovary:10 years follow-up data of 65 patients显示文摘	Sehouli J Drescher FS Mustea A	2004	Anticancer Res2004，24，2：	1
11	Optimization of Medium Components in Vitamin B12 Biosynthesis显示文摘	Roman RV Iuc E Mustea A	2001	Roum Biotechnol Lett2001，6，4：	1
12	Granulosa cell tumor of the Ovary: 10 years follow - up data of 65 patients 显示文摘	Sehouli J Drescher FS Mustea A	2004	Anticancer Res2004，24，2：	1
13	Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer:results of a prospective randomized trial显示文摘	Kohler C Mustea A Marnitz S	2015	Am J Obstet Gynecol2015，213，：	1
14	Polymorphism of IL-la,IL-1βand IL-10 in patients with advanced ovarian cancer:Results of a prospective study with 147 patients显示文摘	Ioans Braicu E Mustea A Toliat MR	2007	Gynecol Oncol2007，104，3：	1
15	Granulosa cell tumor of the Ovary:10 years follow-up data of 65 patients显示文摘	Sehouli J Dreacher FS Mustea A	2004	Anticancer Res2004，24，2：	1
16	Weekly paclitaxel and carbopla-tin( PC-W) for patients with primary advanced ovarian cancer: resultsof a multicenter phase-II study of the NOGGO显示文摘	Sehouli J Stengel D Mustea A	2008	Cancer ChemotherPharmacol2008，61，2：	1
17	Optimization of Medium Components in Vitamin B12 Biosynthesis 显示文摘	Roman RV Iluc E Mustea A	2001	Roum Biotechnol Lett2001，6，：	1
18	Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients显示文摘	Sehouli J Drescher FS Mustea A	2004	Anticancer Res2004，24，2：	1
19	Weekly paclitaxel and carboplatin for patients with primary advanced ovarian cancer: results of a mul- ticenter phase-II study of the NOGGO 显示文摘	Sehouli J Stengel D Mustea A	2008	Cancer Chemother Pharmaeol2008，61，2：	1
20	Conventional and experimental prognostic factors in ovarian cancer显示文摘	Sehouli J Mustea A Konsgen D	2004	Zentralbl Gynakol2004，126，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示